Public Act 098-0464
 
HB3003 EnrolledLRB098 10952 HLH 41560 b

    AN ACT concerning State government.
 
    Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
 
    Section 5. The Department of Public Health Powers and
Duties Law of the Civil Administrative Code of Illinois is
amended by adding Section 2310-349 as follows:
 
    (20 ILCS 2310/2310-349 new)
    Sec. 2310-349. The Childhood Cancer Research Board.
    (a) The Childhood Cancer Research Board is created as an
advisory board within the Department. The Board shall consist
of 11 members as follows: 2 members appointed by the President
of the Senate; one member appointed by the Minority Leader of
the Senate; 2 members appointed by the Speaker of the House of
Representatives; one member appointed by the Minority Leader of
the House of Representatives; 2 members appointed by the
Governor, one of whom shall be designated as chair of the Board
at the time of appointment; and 2 members appointed by the
Director. The Director, or his or her designee, shall serve as
an ex officio member of the Board. Members appointed under this
Section shall be experts in pediatric cancer or members of the
General Assembly; however, no appointing authority may appoint
more than one member of the General Assembly to serve during
the same term. For the purposes of this Section, an "expert in
pediatric cancer" is defined as a physician or scientist who
(i) holds a position of leadership in an internationally
recognized program of pediatric cancer research at the time of
his or her appointment, or (ii) is a fully tenured professor at
an institution of higher education. In addition, an expert in
pediatric cancer must possess at least one of the following
qualifications:
        (1) a strong track record of publication;
        (2) participation in a federally-funded pediatric
    cancer research program;
        (3) a leadership role in a national cancer research
    society, including the American Society of Hematology, the
    American Association of Cancer Research, or the American
    Society of Clinical Oncology; and
        (4) participation in a National Cancer Institute or
    American Cancer Society study section.
    The Board members shall serve one 2-year term. If a vacancy
occurs in the Board membership, the vacancy shall be filled in
the same manner as the initial appointment.
    (b) Board members shall serve without compensation and
shall not be reimbursed for necessary expenses incurred in the
performance of their duties unless funds become available to
the Board. The Department shall provide staff and
administrative support services to the Board.
    (c) The Board must review grant applications, make
recommendations and comments, and consult with the Department
of Public Health in making grants from amounts appropriated
from the Childhood Cancer Research Fund to public or private
not-for-profit entities for the purpose of conducting
childhood cancer research in accordance with Section 6z-93 of
the State Finance Act.
    (d) Grants shall be awarded to research projects that fall
within the following categories:
        (1) understanding the basic biology of specific
    pediatric cancers using cellular and animal models;
        (2) pre-clinical studies that translate basic
    observations into novel diagnostics or therapeutic agents
    specific to pediatric cancer; or
        (3) support of Phase I clinical trials of new agents
    developed at Illinois institutions.
    (e) The Board shall make its recommendations to the
Department no later than March 1 of the year after the
application is received.